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ход отрубов, содержащих наиболее ценные сорта, мясо характеризуется бо-
гатым белковым комплексом. 
Для создания стада животных имеющих высокую мясную продук-
тивность необходимо использование современных методов генетики и мо-
лекулярной биологии. 
Современные молекулярно–генетические методы позволяют опреде-
лить наличие ценных вариантов генов связанных с признаками продуктив-
ности. Выявление предпочтительных вариантов таких генов (генов–
кандидатов) позволит дополнительно к традиционным методам отбора жи-
вотных, проводить маркер–зависимую селекцию [2,4]. 
В качестве маркера мясной продуктивности нами был выбран ген 
миостатин (MSTN), оказывающий влияние на качественные показатели мя-
са крупного рогатого скота абердин–ангусской породы. Белок, кодируемый 
этим геном, ингибирует развитие мышечных тканей у крупного рогатого 
скота. 
Дальнейшие наши исследования предусматривают проведение науч-
но–производственных опытов, изучение влияние генотипов гена миостати-
на (MSTN) на показатели мясной продуктивности животных, в частности, 
на качество мяса крупного рогатого скота абердин–ангусской породы. 
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Platelets play an important role in the process of tumor angiogenesis. The 
onset of tumor angiogenesis involves a net change in balance between 
angiogenesis stimulators and inhibitors in favor of the former. Platelets are a rich 
source of proangiogenic factors. They also store and release angiogenesis 






the process of angiogenesis. Activated platelets serve as procoagulant surfaces 
amplifying the coagulation reactions [1]. 
The elucidation of regulation of the platelet functioning by 
plasminogen/plasmin system is one of the priority areas of our research. 
Plasminogen/plasmin molecule proteolysis in the organism leads to the formation 
of kringle–containing fragments (К 1–3, К 1–4, К 5 etc.) − angiostatins, that 
exhibit an anti–angiogenic effect. It has been shown that angiostatins are 
involved in signaling mechanisms that underlie many normal and 
pathophysiological processes in the organism, such as cell migration, 
angiogenesis, metastasis, tissue remodeling, wound healing, axon germination, 
and others. Thus, the interaction of angiostatins with targets on the plasma 
membrane of endothelial cell (ATP synthase, integrin αVβ3, c–met receptor of 
HGF etc.) leads to suppression of proliferative activity of cells and their ability to 
move and migrate [2]. For some time it was believed that angiostatine is 
produced in the organism by some types of tumors, and indeed, an increase of 
their generation is observed in tumor growth. However, it has recently been 
established that angiostatin is found in the organism and under normal 
conditions, thus, being involved in physiological processes. To date, only a few 
types of cells that are capable of generating angiostatin in the norm are identified, 
including monocytes and macrophages. 
To determine the role of platelets in angiogenesis, we are investigating 
their ability to generate plasminogen fragments – angiostatins, internalize and 
secrete of formed angiostatins by native and activated platelets. 
Materials and methods. Plasminogen was obtained from Cohn fraction 
III2,3 of a human blood plasma ("Kiev municipal blood center", Ukraine) on the 
Lys–Sepharose in the presence of protease inhibitor kontrikal ("AWD", Germany) 
[3]. Mini–Pg was obtained by the limited hydrolysis of Pg with pancreatic elastase 
(3.4.21.36) ("Sigma", USA) [3]. Degradation of mini–Pg was performed with 
pepsin (3.4.23.1), the proteolytic hydrolase from pig gastric mucosa, ("Sigma", 
USA) [3]. All of the used chemical reagents were qualified not less than "chemical 
pure". 
Methods used were: proteolytic fragmentation methods, affinity 
chromatography, ultrafiltration, gel filtration, ion–exchange chromatography, 
ELISA, Western blot analysis, electrophoresis in polyacrylamide gel, 
immunization, etc. 
Statistical processing of experimental data was performed using Prism 5 
software (GraphPad Software Inc., USA). Only the experimental results with the 
error not exceeding 5 % (P < 0.05) are included in the work. Blot results 
presented in the figures are typical for repeated experiments (at least three 
repetitions). 
Results and discussion. To have an instrument to our assay we developed 
a method for producing a functionally active fragment of human plasminogen 
kringle 5 using AH–Sepharose. Proposed method includes the following stages: 
hydrolysis of plasminogen with elastase, separating the mini–plasminogen from 
kringle fragments 1–3 and 4 on the Lys–Sepharose, mini–plasminogen 







electrophoresis in polyacrylamide gel [3]. It was obtained electrophoretically 
pure fragment of human plasminogen kringle 5, while the ability of kringle 5 to 
bind specifically with the AH–Sepharose demonstrates its functional activity 
with respect to the ligands of high and low molecular weight. Weight yield was 
4.1%, which corresponds to 27.3% of the theoretically possible. 
Then our aim was to obtain the polyclonal antibodies against to fragments 
of human plasminogen kringle 5 and kringle 1–3, received in the obtaining 
process of kringle 5. The following approaches were used: immunization of 
rabbits against the kringle 5 and kringle 1–3, receiving of high titer immune 
serum, synthesis of affinity sorbent based on the kringle 5 and kringle 1–3 for 
selection of monospecific antibodies, chromatography on synthesized K5–
Sepharose and K1–3–Sepharose, ELISA, analytical electrophoresis in 
polyacrylamide gel, immunoblotting assay [4, 5]. 
For the obtained affinity sorbents, the ligand binding to BrCN–Sepharose 
was no less than 90 %. The received column had capacity per ligand no less than 
75 nmol per 1g of BrCN–Sepharose, and capacity for binding antibodies of 1.0 ÷ 
1.5 nmol per 1g of BrCN–Sepharose. The content of the obtained 
immunoglobulins in preparations evaluated by electrophoresis was no less than 95 
%, the output of polyclonal antibodies was no less than 1 mg per 1 ml of immune 
serum. 
Further immunochemical properties of obtained antibodies were studied 
by ELISA and immunoblotting assay. It has been found that polyclonal 
antibodies against to kringle 5 and kringle 1–3 are monospecific and have a high 
affinity to their epitopes (the dissociation constants of the value order 10
–10
 M). 
So, such antibodies were found to be applicable in our research. 
 
 
Figure 1 – Proteins detected by the means of polABs specific to K 1–3 (A) or 
K 5 (B) on the membranes (2) and in the lysates (3) of the platelets; 1 – molecular 
weight markers. Platelets were preincubated with K 1–3 (A) or K 5 (B). 
 







We obtained preliminary data on the interaction of isolated K 1–3 and K 5 
plasminogen fragments (angiostatins) with the platelet surface. Detection of 
angiostatins was carried out by western blotting assay using polyclonal 
antibodies (polABs) monospecific to K 1–3 and K 5, which have been obtained 
by us for this purpose. Results concerning fragments of plasminogen found on 
the membranes and in the lysates of the platelets by the means of polABs specific 
to K 1–3 (A) or K 5 (B). are presented in Figure 1. After previous incubation of 
platelets with K 1–3 and K 5, the fragments were detected in isolated plasma 
membranes and absent in cell lysates. The antibodies to K 1–3 revealed 
plasminogen and 51 kDa angiostatin–like fragment on membranes and in lysates, 
whereas antibodies to K 5 revealed miniplasminogen on membranes, and a 
microplasminogen in the inner medium of the cells, indicating the ability of 




Figure 2 – Scheme of possible proteolytic cleavage of plasminogen molecules 
(A). Scheme of plasminogen molecules (B). 
 
Conclusions. There are binding sites for plasminogen kringles 1–3 and 5 
on the surface of platelets. K 1–3 and K 5 are bound to the surface membranes 
but do not pass inside the cell. Plasminogen is detected in the inner medium of 
the platelets and it may undergo proteolytic fragmentation. This data was 
obtained by the means of polABs specific to K 1–3 or K 5.   
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